It appears you don't have support to open PDFs in this web browser. To view this file, Open with your PDF reader
Abstract
Proteins are the biological macromolecules central to most cellular functions. The native structure of protein determines its function and any perturbations such as mutation, changes in pH, macromolecular crowding, oxidative stress, may promote protein misfolding and/or aggregation. Protein misfolding or aggregation can contribute to diseases either through loss of proteins’ critical function or by gain of toxic function. Among the various proteins associated with neurodegeneration, trans-active response (TAR) DNA binding protein 43 (TDP-43) has sparked interest in researchers due to its diverse role in several neurodegenerative diseases like Amyotrophic Lateral Sclerosis (ALS), Frontotemporal Lobar degeneration (FTLD), Alzheimer’s, Parkinson’s and Huntington’s disease. Most of the reported work on TDP-43 protein have been carried out on truncated version of the protein from prokaryotic source due to difficulty in expressing and purifying the full-length protein. Another protein, amyloid β peptides role in Alzheimer’s disease has been studied in great detail. However, the role posttranslational modifications play in Aβ related toxicity has not been fully explored. In this dissertation, I address these two major gaps as follows: 1) I have successfully purified full-length TDP-43 protein using a eukaryotic source and carried out some physicochemical characterization. Now this full-length protein which is from eukaryotic source can be used to better understand proteins role in health and disease. 2) I explored the physicochemical properties of acetylated Amyloid β peptides including its effects on modulating toxicity in SH-SY5Y cell lines (neuroblastoma) and primary neuronal cultures. This work underscores the importance of posttranslational modification such as acetylation of Aβ peptides on toxicity as well as aggregate morphology which will lead to better drug designs in future.
You have requested "on-the-fly" machine translation of selected content from our databases. This functionality is provided solely for your convenience and is in no way intended to replace human translation. Show full disclaimer
Neither ProQuest nor its licensors make any representations or warranties with respect to the translations. The translations are automatically generated "AS IS" and "AS AVAILABLE" and are not retained in our systems. PROQUEST AND ITS LICENSORS SPECIFICALLY DISCLAIM ANY AND ALL EXPRESS OR IMPLIED WARRANTIES, INCLUDING WITHOUT LIMITATION, ANY WARRANTIES FOR AVAILABILITY, ACCURACY, TIMELINESS, COMPLETENESS, NON-INFRINGMENT, MERCHANTABILITY OR FITNESS FOR A PARTICULAR PURPOSE. Your use of the translations is subject to all use restrictions contained in your Electronic Products License Agreement and by using the translation functionality you agree to forgo any and all claims against ProQuest or its licensors for your use of the translation functionality and any output derived there from. Hide full disclaimer